| For: | Pallotta N, Barberani F, Hassan NA, Guagnozzi D, Vincoli G, Corazziari E. Effect of infliximab on small bowel stenoses in patients with Crohn’s disease. World J Gastroenterol 2008; 14(12): 1885-1890 [PMID: 18350627 DOI: 10.3748/wjg.14.1885] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i12/1885.htm |
| Number | Citing Articles |
| 1 |
Muaad Abdulla, Thean Soon Chew. Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease. Current Opinion in Gastroenterology 2021; 37(3) doi: 10.1097/MOG.0000000000000729
|
| 2 |
Jie Wang, Mei Bai, Cui Zhang, Ning An, Li Wan, Xiao-ning Wang, Rong-hui Du, Yan Shen, Zhi-yao Yuan, Xu-dong Wu, Xue-feng Wu, Qiang Xu. Natural compound fraxinellone ameliorates intestinal fibrosis in mice via direct intervention of HSP47-collagen interaction in the epithelium. Acta Pharmacologica Sinica 2023; 44(12) doi: 10.1038/s41401-023-01143-1
|
| 3 |
Florian Rieder, Giovanni Latella, Fernando Magro, Elif S. Yuksel, Peter D. R. Higgins, Antonio Di Sabatino, Jessica R. de Bruyn, Jordi Rimola, Jorge Brito, Dominik Bettenworth, Gert van Assche, Willem Bemelman, Andre d’Hoore, Gianluca Pellino, Axel U. Dignass. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. Journal of Crohn's and Colitis 2016; 10(8) doi: 10.1093/ecco-jcc/jjw055
|
| 4 |
Renata Curciarello, Guillermo H. Docena, Thomas T. MacDonald. The Role of Cytokines in the Fibrotic Responses in Crohn’s Disease. Frontiers in Medicine 2017; 4 doi: 10.3389/fmed.2017.00126
|
| 5 |
Yifei Wang, Yaqin Zhang, Bing Lu, Jianbo Xi, Dickson Kofi Wiredu Ocansey, Fei Mao, Donglin Hao, Yongmin Yan, Tianxiao Zhang. hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts. Stem Cells International 2023; 2023 doi: 10.1155/2023/2828981
|
| 6 |
Bhaskar Kante, Sudheer Kumar Vuyyuru, Saurabh Kedia, Pabitra Sahu, Peeyush Kumar, Mukesh Kumar Ranjan, Shubi Virmani, Raju Sharma, Kumble Seetharama Madhusudhan, Rajesh Panwar, Prasenjit Das, Govind Makharia, Vineet Ahuja. Monotherapy with thiopurines in stricturing Crohn’s disease: A real-life experience from low- and middle-income countries. Indian Journal of Gastroenterology 2022; 41(4) doi: 10.1007/s12664-022-01258-z
|
| 7 |
Tsutomu Masuda, Naoki Inatsugi, Shusaku Yoshikawa, Hideki Uchida, Hiroyuki Kuge, Tomoyo Yokotani, Kentaro Yamaoka, Mizumi Inagaki, Takayoshi Shimobayashi, Takashi Yokoo, Hidetoshi Nishiwaki. Pyogenic Spondylitis Following Crohn's Disease - A Case Report. Nippon Daicho Komonbyo Gakkai Zasshi 2013; 66(7) doi: 10.3862/jcoloproctology.66.504
|
| 8 |
Emma Calabrese, Christian Maaser, Francesca Zorzi, Klaus Kannengiesser, Stephen B. Hanauer, David H. Bruining, Marietta Iacucci, Giovanni Maconi, Kerri L. Novak, Remo Panaccione, Deike Strobel, Stephanie R. Wilson, Mamoru Watanabe, Francesco Pallone, Subrata Ghosh. Bowel Ultrasonography in the Management of Crohnʼs Disease. A Review with Recommendations of an International Panel of Experts. Inflammatory Bowel Diseases 2016; 22(5) doi: 10.1097/MIB.0000000000000706
|
| 9 |
Winnie Chuck, Bruce Frederick Shadbolt, Fariza Nordin, Kavitha Subramaniam. BMI is important in predicting the loss of response in inflammatory bowel disease patients on tumour necrosis factor-α inhibitors. European Journal of Gastroenterology & Hepatology 2022; 34(6) doi: 10.1097/MEG.0000000000002371
|
| 10 |
Guillaume Bouguen, Laurent Siproudhis, Jean-François Bretagne, Marc-André Bigard, Laurent Peyrin-Biroulet. Nonfistulizing perianal Crohnʼs disease. Inflammatory Bowel Diseases 2010; 16(8) doi: 10.1002/ibd.21261
|
| 11 |
Amanda B. Muir, Kara Dods, Yuli Noah, Sarit Toltzis, Prasanna Modayur Chandramouleeswaran, Anna Lee, Alain Benitez, Adam Bedenbaugh, Gary W. Falk, Rebecca G. Wells, Hiroshi Nakagawa, Mei-Lun Wang. Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition. Experimental Cell Research 2015; 330(1) doi: 10.1016/j.yexcr.2014.08.026
|
| 12 |
Silvio Danese, Stefanos Bonovas, Anthony Lopez, Gionata Fiorino, William J. Sandborn, David T. Rubin, Michael A. Kamm, Jean-Frederic Colombel, Bruce E. Sands, Severine Vermeire, Julian Panes, Gerhard Rogler, Geert D’Haens, Laurent Peyrin-Biroulet. Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease. Gastroenterology 2018; 155(1) doi: 10.1053/j.gastro.2018.03.032
|
| 13 |
Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán. Agentes anti-factor de necrosis tumoral en enfermedad de Crohn y colitis ulcerosa: más allá de la enfermedad luminal. Gastroenterología y Hepatología 2018; 41(9) doi: 10.1016/j.gastrohep.2018.06.010
|
| 14 |
Mansour Alourfi, Mahmoud Mosli, Omar I Saadah. The Efficacy of Anti-Tumor Necrosis Factor Alpha for Symptomatic Stricturing Small Bowel Crohn’s Disease. Cureus 2020; doi: 10.7759/cureus.10315
|
| 15 |
Giovanna Condino, Emma Calabrese, Francesca Zorzi, Sara Onali, Elisabetta Lolli, Fabiola De Biasio, Marta Ascolani, Francesco Pallone, Livia Biancone. Anti-TNF-alpha treatments and obstructive symptoms in Crohn's Disease: A prospective study. Digestive and Liver Disease 2013; 45(3) doi: 10.1016/j.dld.2012.10.009
|
| 16 |
Yoram Bouhnik, Franck Carbonnel, David Laharie, Carmen Stefanescu, Xavier Hébuterne, Vered Abitbol, Maria Nachury, Hedia Brixi, Arnaud Bourreille, Laurence Picon, Anne Bourrier, Matthieu Allez, Laurent Peyrin-Biroulet, Jacques Moreau, Guillaume Savoye, Mathurin Fumery, Stephane Nancey, Xavier Roblin, Romain Altwegg, Guillaume Bouguen, Gilles Bommelaer, Silvio Danese, Edouard Louis, Magaly Zappa, Jean-Yves Mary. Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut 2018; 67(1) doi: 10.1136/gutjnl-2016-312581
|
| 17 |
Sachiko Matsuzaki, Jean-Luc Pouly, Michel Canis. Dose-dependent pro- or anti-fibrotic responses of endometriotic stromal cells to interleukin-1β and tumor necrosis factor α. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66298-x
|
| 18 |
Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E. Parker, Zahra Premji, Stephanie R. Wilson, Mark E. Baker, Gauraang Bhatnagar, Jakob Begun, David H. Bruining, Robert Bryant, Britt Christensen, Brian G. Feagan, Joel G. Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri Novak, Jordi Rimola, Stuart A. Taylor, Rune Wilkens, Florian Rieder. Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary Pharmacology & Therapeutics 2024; 59(8) doi: 10.1111/apt.17918
|
| 19 |
Joseph Sleiman, Sara El Ouali, Taha Qazi, Benjamin Cohen, Scott R. Steele, Mark E. Baker, Florian Rieder. Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges. Expert Review of Gastroenterology & Hepatology 2021; 15(4) doi: 10.1080/17474124.2021.1854732
|
| 20 |
Fotios Fousekis, Ioannis Mitselos, Kostas Tepelenis, George Pappas-Gogos, Konstantinos Katsanos, Georgios Lianos, Francesco Frattini, Konstantinos Vlachos, Dimitrios Christodoulou. Medical, Endoscopic and Surgical Management of Stricturing Crohn’s Disease: Current Clinical Practice. Journal of Clinical Medicine 2022; 11(9) doi: 10.3390/jcm11092366
|
| 21 |
Cathy Lu, Brandon Baraty, Helen Lee Robertson, Alexis Filyk, Hua Shen, Tak Fung, Kerri Novak, Christopher Ma, Remo Panaccione, Jean‐Paul Achkar, Sara El Ouali, David Bruining, Vipul Jairath, Brian Feagan, Florian Rieder. Systematic review: medical therapy for fibrostenosing Crohn’s disease. Alimentary Pharmacology & Therapeutics 2020; 51(12) doi: 10.1111/apt.15750
|
| 22 |
Shigeki Bamba, Ryosuke Sakemi, Toshimitsu Fujii, Teruyuki Takeda, Shin Fujioka, Kento Takenaka, Hiroki Kitamoto, Shotaro Umezawa, Hirotake Sakuraba, Toshihiro Inokuchi, Norimasa Fukata, Shinta Mizuno, Masaki Yamashita, Shinichiro Shinzaki, Hiroki Tanaka, Hidetoshi Takedatsu, Ryo Ozaki, Kei Moriya, Manabu Ishii, Tetsu Kinjo, Keiji Ozeki, Makoto Ooi, Ryohei Hayashi, Kazuki Kakimoto, Yuichi Shimodate, Kazuya Kitamura, Akihiro Yamada, Akira Sonoda, Yu Nishida, Kyouko Yoshioka, Shinya Ashizuka, Fumiaki Takahashi, Toshio Shimokawa, Taku Kobayashi, Akira Andoh, Toshifumi Hibi. A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn’s disease. Journal of Gastroenterology 2020; 55(6) doi: 10.1007/s00535-020-01670-2
|
| 23 |
Si-Nan Lin, Ren Mao, Chenchen Qian, Dominik Bettenworth, Jie Wang, Jiannan Li, David H. Bruining, Vipul Jairath, Brian G. Feagan, Min-Hu Chen, Florian Rieder. Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases. Physiological Reviews 2022; 102(2) doi: 10.1152/physrev.00005.2021
|
| 24 |
Naïk Vietti Violi, Alain M. Schoepfer, Nicolas Fournier, Boris Guiu, Pierre Bize, Alban Denys. Prevalence and Clinical Importance of Mesenteric Venous Thrombosis in the Swiss Inflammatory Bowel Disease Cohort. American Journal of Roentgenology 2014; 203(1) doi: 10.2214/AJR.13.12447
|
| 25 |
Consensus guidelines for the management of inflammatory bowel disease. Arquivos de Gastroenterologia 2010; 47(3) doi: 10.1590/S0004-28032010000300019
|
| 26 |
Eran Zittan, Ian M. Gralnek, Marc S. Berns. The New Proactive Approach and Precision Medicine in Crohn’s Disease. Biomedicines 2020; 8(7) doi: 10.3390/biomedicines8070193
|
| 27 |
Elettra Merola, Daniele La Rocca, Mariano Scaglione, Giovanni Mario Pes, Maria Pina Dore. The missing evidence: Stricturing Crohn’s disease in clinical trials, a systematic review. Inflammatory Bowel Diseases 2026; doi: 10.1093/ibd/izag079
|
| 28 |
Bo Shen. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications. 2018; doi: 10.1016/B978-0-12-811388-2.00022-1
|
| 29 |
Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán. Anti-tumour necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease. Gastroenterología y Hepatología (English Edition) 2018; 41(9) doi: 10.1016/j.gastre.2018.06.014
|
| 30 |
Virginia Solitano, Arianna Dal Buono, Roberto Gabbiadini, Marek Wozny, Alessandro Repici, Antonino Spinelli, Stefania Vetrano, Alessandro Armuzzi. Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next?. Journal of Clinical Medicine 2023; 12(9) doi: 10.3390/jcm12093052
|
| 31 |
Grace C. Lovett, Julien D. Schulberg, Amy L. Hamilton, Emily K. Wright, Bronte A. Holt, Tom R. Sutherland, Alyson L. Ross, Michael A. Kamm. Long-term Results of Drug Treatment for Crohn’s Disease Strictures. Clinical Gastroenterology and Hepatology 2025; doi: 10.1016/j.cgh.2025.09.014
|
| 32 |
Carme Loras, Miriam Mañosa, Xavier Andújar, Vicente Sánchiz, Marc Martí-Gallostra, Yamile Zabana, Ana Gutiérrez, Manuel Barreiro-de Acosta. Documento de posicionamiento. Recomendaciones del grupo español de trabajo en enfermedad de Crohn y colitis ulcerosa (GETECCU) sobre el tratamiento de la estenosis en la enfermedad de Crohn. Gastroenterología y Hepatología 2022; 45(4) doi: 10.1016/j.gastrohep.2021.07.001
|
| 33 |
Irene Mignini, Valentina Blasi, Fabrizio Termite, Giorgio Esposto, Raffaele Borriello, Lucrezia Laterza, Franco Scaldaferri, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Fibrostenosing Crohn’s Disease: Pathogenetic Mechanisms and New Therapeutic Horizons. International Journal of Molecular Sciences 2024; 25(12) doi: 10.3390/ijms25126326
|
| 34 |
Yifei Wang, Bin Huang, Tao Jin, Dickson Kofi Wiredu Ocansey, Jiajia Jiang, Fei Mao. Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.835005
|
| 35 |
Jakob Hendel, John Gásdal Karstensen, Peter Vilmann. Serial intralesional injections of infliximab in small bowel Crohn's strictures are feasible and might lower inflammation. United European Gastroenterology Journal 2014; 2(5) doi: 10.1177/2050640614547805
|
| 36 |
Nik Arsyad Nik Affendi, Ida Hilmi. Endoscopy for Crohn's disease‐related strictures: Can we finally replace the surgeons?. Journal of Gastroenterology and Hepatology 2024; 39(5) doi: 10.1111/jgh.16522
|
| 37 |
Ze‐min Han, Welera Haissou Elodie, Wen‐juan Zhang, Pei‐chun Xu, Li‐hua Yan, Fa‐chao Zhi, Xin‐mei Zhao. Ultrasound Is Valuable in Assessing Treatment Response, Guiding Treatment Strategy, and Predicting Outcomes in Small Bowel Stricturing Crohn's Disease. Journal of Ultrasound in Medicine 2026; 45(6) doi: 10.1002/jum.70170
|
| 38 |
Ajinkya Ashok Sonambekar, Devendra C Desai, Anand Joshi, Pavan Dhoble. Adalimumab in Crohn's strictures––the CREOLE study. Gut 2018; 67(1) doi: 10.1136/gutjnl-2017-314124
|
| 39 |
Mohamed Saleh Ismail, Aline Charabaty. Management of Crohn’s stricture: medical, endoscopic and surgical therapies. Frontline Gastroenterology 2022; 13(6) doi: 10.1136/flgastro-2021-101827
|
| 40 |
Grace C Lovett, Julien D Schulberg, Amy L Hamilton, Emily K Wright, Tom R Sutherland, Alyson L Ross, Michael A Kamm. Crohn’s Disease Stricture Response to Treatment Assessed with Magnetic Resonance Imaging and Intestinal Ultrasound: STRIDENT Randomized Trial. Inflammatory Bowel Diseases 2025; 31(10) doi: 10.1093/ibd/izaf073
|
| 41 |
Roy Frei, Nicolas Fournier, Jonas Zeitz, Michael Scharl, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann. Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn’s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study. Journal of Crohn's and Colitis 2019; 13(10) doi: 10.1093/ecco-jcc/jjz057
|
| 42 |
Giovanni Di Nardo, Salvatore Oliva, Maurizio Passariello, Nadia Pallotta, Fortunata Civitelli, Simone Frediani, Gianfranco Gualdi, Paolo Gandullia, Saverio Mallardo, Salvatore Cucchiara. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointestinal Endoscopy 2010; 72(6) doi: 10.1016/j.gie.2010.08.003
|
| 43 |
Shomron Ben-Horin, Niels Vande Casteele, Stefan Schreiber, Peter Laszlo Lakatos. Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation. Clinical Gastroenterology and Hepatology 2016; 14(12) doi: 10.1016/j.cgh.2016.05.023
|
| 44 |
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet, Silvio Danese. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nature Reviews Gastroenterology & Hepatology 2022; 19(3) doi: 10.1038/s41575-021-00543-0
|
| 45 |
Muniratu Amadu, Jonathan Soldera. Duodenal Crohn’s disease: Case report and systematic review. World Journal of Methodology 2024; 14(1): 88619 doi: 10.5662/wjm.v14.i1.88619
|
| 46 |
Alexander T. Elford, Zaid Ardalan, Paul Simkin, Britt Christensen. Comprehensive review and update of stricturing Crohn’s disease. Indian Journal of Gastroenterology 2024; 43(1) doi: 10.1007/s12664-023-01508-8
|
| 47 |
Mariangela Allocca, Cristiana Bonifacio, Gionata Fiorino, Antonino Spinelli, Federica Furfaro, Luca Balzarini, Stefanos Bonovas, Silvio Danese. Efficacy of tumour necrosis factor antagonists in stricturing Crohn’s disease: A tertiary center real-life experience. Digestive and Liver Disease 2017; 49(8) doi: 10.1016/j.dld.2017.03.012
|
| 48 |
Sachiko Matsuzaki, Jean-Luc Pouly, Michel Canis. IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression. Human Reproduction 2023; 38(1) doi: 10.1093/humrep/deac248
|
| 49 |
Jonathan J. Neville, Alexander Macdonald, John Fell, Muhammad Choudhry, Munther Haddad. Therapeutic strategies for stricturing Crohn’s disease in childhood: a systematic review. Pediatric Surgery International 2021; 37(5) doi: 10.1007/s00383-020-04848-0
|
| 50 |
Brice Malgras, Karine Pautrat, Xavier Dray, Pierre Pasquier, Patrice Valleur, Marc Pocard, Philippe Soyer. Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease. Digestive Diseases and Sciences 2015; 60(5) doi: 10.1007/s10620-014-3421-y
|
| 51 |
Cristiano Pagnini, Kristen O Arseneau, Fabio Cominelli. Safety considerations when using anti-TNFα therapy to treat Crohn’s disease. Expert Opinion on Drug Safety 2015; 14(1) doi: 10.1517/14740338.2015.976610
|
| 52 |
Lei Lian, Luca Stocchi, Bo Shen, Xiaobo Liu, Jessica Ma, Brook Zhang, Feza Remzi. Prediction of Need for Surgery After Endoscopic Balloon Dilation of Ileocolic Anastomotic Stricture in Patients With Crohn’s Disease. Diseases of the Colon & Rectum 2015; 58(4) doi: 10.1097/DCR.0000000000000322
|
| 53 |
Yukie Hayashi, Kaoru Takabayashi, Naoki Hosoe, Hiroki Kiyohara, Satoshi Kinoshita, Kosaku Nanki, Kayoko Fukuhara, Yohei Mikami, Tomohisa Sujino, Makoto Mutaguchi, Takaaki Kawaguchi, Motohiko Kato, Haruhiko Ogata, Takanori Kanai. Predictors of necessity for endoscopic balloon dilatation in patients with Crohn’s disease-related small bowel stenosis. Annals of Medicine 2021; 53(1) doi: 10.1080/07853890.2021.1998597
|
| 54 |
Jose Luis Rueda García, Cristina Suárez-Ferrer, Joaquín Poza Cordón, Eduardo Martín-Arranz, María Sánchez Azofra, Laura García Ramírez, Jesús Noci, María Dolores Martín-Arranz. Doppler Activity and Ultrasonographic Detection of Intra-Abdominal Fistulas Are Predictors of Surgery in Crohn’s Disease. Digestive Diseases 2021; 39(3) doi: 10.1159/000511075
|
| 55 |
Sudheer K. Vuyyuru, Bhaskar Kante, Peeyush Kumar, Pabitra Sahu, Saurabh Kedia, Mukesh Kumar Ranjan, Raju Sharma, Rajesh Panwar, Govind Makharia, Vineet Ahuja. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90660-2
|
| 56 |
W. Miehsler, G. Novacek, H. Wenzl, H. Vogelsang, P. Knoflach, A. Kaser, C. Dejaco, W. Petritsch, M. Kapitan, H. Maier, W. Graninger, H. Tilg, W. Reinisch. A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. Journal of Crohn's and Colitis 2010; 4(3) doi: 10.1016/j.crohns.2009.12.001
|
| 57 |
S M Sahebally, J P Burke, K H Chang, M G Kiernan, P R O'Connell, J C Coffey. Circulating fibrocytes and Crohn's disease. British Journal of Surgery 2013; 100(12) doi: 10.1002/bjs.9302
|
| 58 |
Shishira Bharadwaj, Phillip Fleshner, Bo Shen. Therapeutic Armamentarium for Stricturing Crohnʼs Disease. Inflammatory Bowel Diseases 2015; 21(9) doi: 10.1097/MIB.0000000000000403
|
| 59 |
Eoin Slattery, Denise Keegan, Diarmuid O'Donoghue. Anorectal stenosis after treatment with tumor necrosis factor α antibodies: a case series. Journal of Medical Case Reports 2010; 4(1) doi: 10.1186/1752-1947-4-226
|
| 60 |
Julien D Schulberg, Emily K Wright, Bronte A Holt, Helen E Wilding, Amy L Hamilton, Alyson L Ross, Michael A Kamm. Efficacy of drug and endoscopic treatment of Crohn's disease strictures: A systematic review. Journal of Gastroenterology and Hepatology 2021; 36(2) doi: 10.1111/jgh.15330
|
| 61 |
Carme Loras, Miriam Mañosa, Xavier Andújar, Vicente Sánchiz, Marc Martí-Gallostra, Yamile Zabana, Ana Gutiérrez, Manuel Barreiro-de Acosta. Position Statement. Recommendations of the Spanish Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on the treatment of strictures in Crohn’s disease. Gastroenterología y Hepatología (English Edition) 2022; 45(4) doi: 10.1016/j.gastre.2022.04.002
|
| 62 |
Florian Rieder, Ellen M Zimmermann, Feza H Remzi, William J Sandborn. Crohn's disease complicated by strictures: a systematic review. Gut 2013; 62(7) doi: 10.1136/gutjnl-2012-304353
|
| 63 |
Zemin Han, Weiguang Qiao, Xiuyun Ai, Aimin Li, Zhenyu Chen, Jie Zhang, Tianmo Wan, Xicheng Feng, Side Liu, Fachao Zhi. Risk factors for surgery in patients with retention of endoscopic capsule. Scandinavian Journal of Gastroenterology 2018; 53(1) doi: 10.1080/00365521.2017.1390603
|
| 64 |
Jie Wang, Sinan Lin, Jonathan Mark Brown, David van Wagoner, Claudio Fiocchi, Florian Rieder. Novel mechanisms and clinical trial endpoints in intestinal fibrosis*. Immunological Reviews 2021; 302(1) doi: 10.1111/imr.12974
|
| 65 |
Maarten J Pruijt, Floris A E de Voogd, Nahid S M Montazeri, Faridi S van Etten-Jamaludin, Geert R D’Haens, Krisztina B Gecse. Diagnostic Accuracy of Intestinal Ultrasound in the Detection of Intra-Abdominal Complications in Crohn’s Disease: A Systematic Review and Meta-Analysis. Journal of Crohn's and Colitis 2024; 18(6) doi: 10.1093/ecco-jcc/jjad215
|
| 66 |
Damien Soudan, Yoram Bouhnik. Fibrostenotic Inflammatory Bowel Disease. 2018; doi: 10.1007/978-3-319-90578-5_15
|
| 67 |
Florian Rieder, Claudio Fiocchi, Gerhard Rogler. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases. Gastroenterology 2017; 152(2) doi: 10.1053/j.gastro.2016.09.047
|
| 68 |
Iago Rodríguez-Lago, Javier P Gisbert. The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn’s Disease. Journal of Crohn's and Colitis 2020; 14(4) doi: 10.1093/ecco-jcc/jjz158
|
| 69 |
Ferdinando D’Amico, Nicola Pugliese, Laurent Peyrin-Biroulet, Silvio Danese. Efficacy of anti-TNFα drugs in patients with stricturing Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2020; 14(5) doi: 10.1080/17474124.2020.1759417
|
| 70 |
Giang Quach, Martin D. Zielinski. Surgical management of small bowel obstruction: What you need to know. Journal of Trauma and Acute Care Surgery 2024; 96(3) doi: 10.1097/TA.0000000000004195
|
| 71 |
Cécile Campos, Antoine Perrey, Céline Lambert, Bruno Pereira, Marion Goutte, Anne Dubois, Felix Goutorbe, Michel Dapoigny, Gilles Bommelaer, Constance Hordonneau, Anthony Buisson. Medical Therapies for Stricturing Crohn’s Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure. Digestive Diseases and Sciences 2017; 62(6) doi: 10.1007/s10620-017-4572-4
|
| 72 |
Sara El Ouali, Benjamin Click, Stefan D. Holubar, Florian Rieder. Natural history, diagnosis and treatment approach to fibrostenosing Crohn’s disease. United European Gastroenterology Journal 2020; 8(3) doi: 10.1177/2050640620901960
|
| 73 |
Giovanni Maconi, Elisa Radice, Emilia Bareggi, Gabriele Bianchi Porro. Hydrosonography of the Gastrointestinal Tract. American Journal of Roentgenology 2009; 193(3) doi: 10.2214/AJR.08.1979
|
| 74 |
Shana Rakowsky, Konstantinos Papamichael, Adam S. Cheifetz. Choosing the right biologic for complications of inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2022; 16(3) doi: 10.1080/17474124.2022.2036122
|